Red biotechnology, also known as medical biotechnology, refers to the branch of biotechnology that focuses on the application of genetic engineering and molecular biology to develop innovative medical products and treatments. Unlike green biotechnology, which revolves around agriculture, or white biotechnology, which centers on industrial applications, red biotechnology is dedicated to advancements in healthcare. This field encompasses the development of pharmaceuticals, diagnostic tests, gene therapies, and vaccines. Researchers in red biotechnology work on understanding and manipulating biological processes at the molecular level to create novel medical solutions. Examples of red biotechnology applications include the production of genetically engineered drugs, stem cell therapies, and personalized medicine tailored to an individual's genetic makeup. The continuous progress in red biotechnology holds promise for groundbreaking advancements in medical science and the improvement of healthcare outcomes.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States